0001193125-22-125553 Sample Contracts

ASSET PURCHASE AGREEMENT by and among ERYTECH PHARMA, S.A., ERYTECH PHARMA, INC., CATALENT PRINCETON, LLC and CATALENT PHARMA SOLUTIONS, INC. (solely for purposes of Section 6.17) dated as of April 22, 2022

Asset Purchase Agreement • April 28th, 2022 • Erytech Pharma S.A. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Asset Purchase Agreement
• Filed
  April 28th, 2022
• Company
  Erytech Pharma S.A.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

ASSET PURCHASE AGREEMENT, dated as of April 22, 2022 (this “Agreement”), by and among Erytech Pharma S.A., a French societé anonyme (“Seller”), Erytech Pharma, Inc., a Delaware corporation (“Erytech Inc.”), Catalent Princeton, LLC, a Delaware limited liability company (“Purchaser”) and, solely for purposes of Section 6.17, Catalent Pharma Solutions, Inc., a Delaware corporation (“Purchaser Parent”).